Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet?
NCT05268809 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71
Last updated 2026-01-12
Summary
Wide ranging cognitive deficits are major drivers of functional decline and poor outcomes in people with schizophrenia (SZ) and bipolar disorder (BD). Medications do not target pathophysiological mechanisms thought to underlie these deficits. In the search for interventions targeting underlying cognitive impairment in SZ and BD, we look comprehensively beyond just the brain and to the potential role of dysfunctional systemic metabolism.
Disrupted insulin and glucose metabolism are seen in medication-naïve first-episode SZ, suggesting that SZ itself, and not just the medications used to treat it, is associated with risk of Type 2 diabetes, cardiovascular morbidity and mortality, and more generally, accelerated aging. Even young people with SZ have increased risk of metabolic disease and cognitive deficits. Sadly, their life span is shortened by 15-20 years. BD is associated with similar but less severe disruptions in glucose and insulin metabolism and life expectancy.
Although the human brain is 2% of the body's volume, it consumes over 20% of its energy, and accordingly, the brain is particularly vulnerable to the dysregulation of glucose metabolism seen in SZ and BD. While glucose is considered to be the brain's default fuel, ketones provide 27% more free energy and are a major source of energy for the brain. Ketones prevent or improve various age-associated diseases, and a ketogenic diet (70% fat, 20% protein, 10% carbohydrates) has been posited as an anti-aging and dementia antidote.
The premise of the work is based on recent evidence that ketogenic diets improve dynamic neural network instability, related to cognitive deficits, aging, and Type 2 diabetes (Mujica-Parodi et al., Proc Natl Acad Sci U S A. 2020;117(11):6170-7.). The rigor of the work rests on findings of (1) poor cerebral glucose homeostasis in SZ and BD, (2) neural network instability in SZ and BD, and (3) direct effects of ketosis on network instability. Unknown is whether ketogenic diets can improve network instability in people with SZ and BD.
Conditions
Interventions
- OTHER
-
Ketogenic diet
The ketogenic diet is a normo-caloric diet composed of high-fat (70%), low-carbohydrate (10%), and adequate protein (20%) that induces fasting-like effects and the production of ketone bodies.
Sponsors & Collaborators
-
Northern California Institute of Research and Education
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-21
- Primary Completion
- 2025-08-01
- Completion
- 2025-08-31
Countries
- United States
Study Locations
More Related Trials
-
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism
NCT02675530 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
NCT01988714 ·Status: COMPLETED ·Phase: NA
-
Carnosine and Cognitive Training in Schizophrenia
NCT02686697 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076 ·Status: COMPLETED ·Phase: PHASE2
-
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia
NCT00247637 ·Status: COMPLETED
-
Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia
NCT01399437 ·Status: COMPLETED
-
Gluten Free Diet in People With Schizophrenia: A Pilot Study
NCT01558557 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
NCT00588731 ·Status: COMPLETED ·Phase: PHASE2
-
KetoBrain: Brain Energy Metabolism in Schizophrenia
NCT07309172 ·Status: RECRUITING
-
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
NCT02505477 ·Status: COMPLETED ·Phase: PHASE4
-
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323 ·Status: COMPLETED
-
Prebiotic Treatment in People With Schizophrenia
NCT05527210 ·Status: RECRUITING ·Phase: NA
-
Improving Cognition Via Exercise in Schizophrenia
NCT03270098 ·Status: COMPLETED ·Phase: NA
-
Evaluation Study of New Compounds With Potential Use in Schizophrenia
NCT00916201 ·Status: WITHDRAWN ·Phase: PHASE1
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
Training-induced Cerebral Reorganization in Schizophrenia
NCT00695708 ·Status: COMPLETED ·Phase: NA
-
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers in Schizophrenia
NCT00817336 ·Status: COMPLETED ·Phase: PHASE2
-
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia
NCT03260257 ·Status: COMPLETED ·Phase: NA
-
The Effect of Ketamine on Attentiveness
NCT01165294 ·Status: COMPLETED ·Phase: PHASE1
-
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
NCT00207064 ·Status: COMPLETED ·Phase: NA
-
Energetics and Glutamate in Schizophrenia
NCT06236048 ·Status: RECRUITING
-
Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia
NCT03788759 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia
NCT02237235 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Training for Patients With Schizophrenia
NCT01521026 ·Status: COMPLETED ·Phase: NA